Abacus Health Products (OTCMKTS:ABAHF) Shares Down 5.1% – What’s Next?

Shares of Abacus Health Products Inc (OTCMKTS:ABAHFGet Free Report) were down 5.1% on Thursday . The stock traded as low as $4.60 and last traded at $4.84. Approximately 9,300 shares traded hands during mid-day trading, a decline of 9% from the average daily volume of 10,164 shares. The stock had previously closed at $5.10.

Abacus Health Products Stock Down 5.1%

The firm has a 50 day moving average price of $4.84 and a two-hundred day moving average price of $4.84.

About Abacus Health Products

(Get Free Report)

Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers.

Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms.

See Also

Receive News & Ratings for Abacus Health Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Health Products and related companies with MarketBeat.com's FREE daily email newsletter.